Untitled

Saxe Healthcare Communications* presents…”Safe & Efficient Anesthesia: The Role of Quantitative Neuromuscular Monitoring”

Residual neuromuscular block poses an unnecessary threat to patients. The basic principle for preventing residual neuromuscular block is quantitative neuromuscular monitoring. Three methods of neuromuscular monitoring will be addressed in this webinar: AMG, KMG and EMG. The speakers will discuss a combination of both neuromuscular monitoring and reversal agents, in terms of an algorithm that can reduce incidence and severity of this unwanted anesthetic complication.

Learning Objectives  |  At the end of this session, participants should be able to:

1. Discuss the use of neuromuscular monitoring for the prevention of post-operative residual neuromuscular block during anesthesia.
2. Describe the three (3) technologies of neuromuscular monitoring
3. Discuss the use of both neuromuscular monitoring and reversal agents in combination with an algorithm to reduce anesthetic complications

Speakers:

Manfred Blobner, M.D.  |  Professor of Anesthesia  |  Department of Anaesthesiology & Intensive Care Medicine  |  School of Medicine  |  Technical University of Munich, Germany
Matthias Eikermann, M.D.  |  Professor of Anesthesia  |  Harvard Medical School   |  Boston, MA

Continuing Education Information  |  Continuing Education for Physicians, Nurses & Respiratory Therapists.  This program has been approved for:

• SynAptiv is accredited by the Accreditation Council for Continuing Medical Education (ACCME) for 1 AMA PRA Category 1 Credit.
• Saxe Healthcare Communications is accredited as a provider for continuing education. Provider approved by California Board of Nursing. Provider #14477 and the Florida Board of Nursing Provider # 50-17032.
• This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care.

Support for this educational activity has been provided by GE Healthcare.

Questions should be directed to Saxe Communications: 561-805-5784  |  sshapiro@saxecommunications.com

* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.